// App-Quantinova.ai

S2044 2016 AHA : Consistent Effect of Empagliflozin on Cardiovascular Death in Subgroups by Type of Cardiovascular Disease: Results From EMPA-REG OUTCOME

Researchers

Presenter

  • Silvio E Inzucchi

Principal Investigators

  • John M Lachin

  • Jyothis George

  • Michaela Mattheus

  • Angelo Del Parigi

  • Hans-Juergen Woerle

  • David Fitchett

Medical Centers

  • Yale Univ Schl of Med, New Haven, CT

  • George Mason University, Rockville, MD

  • U Toronto, Toronto, ON, Canada

  • Lunenfeld-Tanenbaum Res Inst, Toronto, ON, Canada

  • Inc, Ridgefield, CT

Locations

  • United States

  • Canada

Companies

  • Boehringer Ingelheim

Study Components

Therapeutic Area

  • Endocrine/metabolic Diseases (ME)

  • Genetic Disorder

Disease

  • Myocardial infarction

  • Type 2 diabetes mellitus

  • Diabetes

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • BI-10773

Outcome

  • N/A

Study Design

  • randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved